Angioplasty overused among millions of patients, evidence shows
Every day, thousands of people enter hospitals for angioplasties—a procedure that will cost about $12,000, take a week of recuperation, and require a year or more of drug therapy. And, in many cases, it's probably unnecessary. Angioplasties have grown into a $10 billion industry in the United States, and there is no dispute that they can be a lifesaver for patients in the throes of a heart attack. But angioplasties aren't risk-free, and evidence is mounting that the procedure is overused among the millions of patients who have the kind of stable heart disease that doesn't foretell a heart attack. New studies indicate that cardiologists often don't evaluate these patients adequately before doing angioplasties, and patients often have inflated ideas about how important an angioplasty is to their survival.
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Acute Kidney Injury Gets New Focus
- Transforming Cancer Care
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- mHealth Tackles Readmissions
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Sharp HealthCare Leaves Pioneer ACO Program
- MA an Insurance Proving Ground for Providers